Originally published In Press as doi:10.1074/jbc.M202146200 on March 14, 2002
J. Biol. Chem., Vol. 277, Issue 21, 19071-19079, May 24, 2002
Characterization of the Matrilin Coiled-coil Domains Reveals
Seven Novel Isoforms*
Sabine
Frank
,
Therese
Schulthess
,
Ruth
Landwehr
,
Ariel
Lustig
,
Thierry
Mini§,
Paul
Jenö§,
Jürgen
Engel
¶, and
Richard A.
Kammerer
**
From the Departments of
Biophysical Chemistry and
§ Biochemistry, Biozentrum, University of Basel, CH-4056
Basel, Switzerland and
Wellcome Trust Centre for Cell-Matrix
Research, University of Manchester,
Manchester M13 9PT, United Kingdom
Received for publication, March 5, 2002
 |
ABSTRACT |
Matrilins constitute a family of four oligomeric
extracellular proteins that are involved in the development and
homeostasis of cartilage and bone. To reveal their homo- and
heterotypic oligomerization propensities, we analyzed the four human
matrilin coiled-coil domains by biochemical and biophysical methods.
These studies not only confirmed the homo- and heterotypic
oligomerization states reported for the full-length proteins but
revealed seven novel matrilin isoforms. Specific heterotrimeric
interactions of variable chain stoichiometries were observed between
matrilin-1 and matrilin-2, matrilin-1 and matrilin-4, and matrilin-2
and matrilin-4. In addition, matrilin-1 formed two different specific
heterotetramers with matrilin-3. Interestingly, a distinct heterotrimer
consisting of three different chains was formed between matrilin-1,
matrilin-2, and matrilin-4. No interactions, however, were observed
between matrilin-2 and matrilin-3 or between matrilin-3 and matrilin-4. Both homo- and heterotypic oligomers folded into parallel
disulfide-linked structures, although coiled-coil formation was not
dependent on disulfide bridge formation. Our results indicate that the
heterotypic preferences seen for the matrilin coiled-coil domains are
the result of the packing of the hydrophobic core rather than ionic interactions. Mass spectrometry revealed that the concentrations of the
individual chains statistically determined the stoichiometry of the
heteromers, suggesting that formation of the different matrillin chain
combinations is controlled by expression levels.
 |
INTRODUCTION |
Matrilins are a family of four modular extracellular matrix
proteins that show a similar structure consisting of one or two von
Willebrand factor A (vWFA)1
domains, a varying number of epidermal growth factor (EGF)-like repeats, and a C-terminal coiled-coil domain (1).
The functions of matrilins are poorly defined. Matrilins may play a
role in stabilizing the extracellular matrix structure, since they can
self-associate into supramolecular structures, resulting in the
formation of filamentous networks (2-7). It has been shown that at
least in the case of matrilin-1 and matrilin-3, these networks can
either be associated with collagen fibrils or be collagen-independent.
In the case of matrilin-1, it appears that the collagen-matrilin
interaction is periodic, and it has been proposed that matrilin-1 may
play a role in collagen fibril assembly (2, 4). Consistent with this
hypothesis, ultrastructural studies of the cartilage of growth plates
of matrilin-1 null mice revealed an abnormal type II collagen
fibrillogenesis and fibril organization in the matrix of the zone of
maturation (8). Furthermore, matrilin-1 binds to the aggrecan core
protein (9) through an interaction that can become covalently
stabilized (10), suggesting a role for matrilins in connecting
different extracellular matrix components over a distance with their
filaments to form an integrated network. In addition to binding to
other matrix proteins, it has been proposed that matrilin-1 interacts
with integrin
1
1 receptors and so may
play a role in cell signaling (11). Recently, it has been demonstrated
that mutations in the vWFA domain in matrilin-3 are associated with
multiple epiphyseal dysplasia (12), confirming a role for the protein
in the development and homeostasis of cartilage and bone.
Matrilin-2 (5, 13) and matrilin-4 (7, 14, 15) have a broad tissue
distribution, whereas the expression of matrilin-1 (also known as
cartilage matrix protein) (9, 16, 17) and matrilin-3 (6, 18-20) is
more restricted to skeletal tissues. However, matrilin-1 expression
appears to be less limited to cartilage during embryonal development
(21). These complementary and in part overlapping expression patterns
of matrilins gain additional potential functional significance through
the recent discovery of hetero-oligomers formed by matrilin-1 and
matrilin-3 in cartilage (6, 22, 23). It was shown that their assembly
was not dependent on the number of EGF-like repeats but on the
presence of the two cysteines within the coiled-coil domain, which form
covalent disulfide bonds responsible for both homo- and
hetero-oligomerization (24). These findings raise the question of
whether hetero-oligomer formation can also exist between other
matrilins. To address this issue, we investigated the homo- and
hetero-oligomerization properties of the four human matrilins. To avoid
difficulties associated with the supramolecular assembly properties of
the proteins, these analyses were limited to the individual coiled-coil
domains produced by recombinant expression in E. coli.
Moreover, coiled-coil domains usually display the same oligomerization
state as the full-length proteins. The structures and assembly products
of the individual proteins and all possible chain combinations were
assessed by SDS-PAGE, nondenaturing PAGE, mass spectrometry, CD
spectroscopy, and analytical ultracentrifugation. These studies not
only confirmed the known homotypic and heterotypic oligomerization
forms reported for the full-length proteins but also revealed seven
novel matrilin chain combinations. We demonstrate that the
concentrations of the individual chains statistically determine the
stoichiometry of the heteromers. Together with the thermodynamic
results that revealed an increased thermal stability of the
hetero-oligomers, this finding suggests that formation of the different
matrillin chain combinations is controlled by expression levels.
 |
EXPERIMENTAL PROCEDURES |
Construction of Expression Plasmids and Production of Recombinant
Proteins--
Synthetic genes encoding the amino acid sequences of the
C-terminal coiled-coil domains of the four matrilin family members shown in Fig. 1B were prepared by PCR with optimal codon
usage for Escherichia coli (25). The PCR products were
ligated into the BamHI/EcoRI site of the
bacterial expression vector pHis, a derivative of pET-15b (Novagen).
Recombinant insert DNA was verified by Sanger dideoxy DNA sequencing.
The recombinant proteins were expressed in E. coli
JM109(DE3) host strain (Novagen). The His6-tagged proteins
were purified by immobilized metal affinity chromatography on
Ni2+-Sepharose (Novagen). Separation of the polypeptide
chain fragments from their His6 tags by thrombin cleavage
was carried out as described in the manufacturer's instructions. The
peptides contain two additional residues, Gly and Ser, at their N
termini. They originate from the expression plasmids and are not part
of the coding sequences. The recombinant polypeptide chain fragments
were analyzed in 5 mM sodium phosphate buffer (pH 7.4)
supplemented with 150 mM sodium chloride. The peptide
concentrations were determined by tryptophan and tyrosine absorption in
6 M GuHCl (26).
Preparation of Disulfide-linked Homo- and
Hetero-oligomers--
The purified matrilin homo-oligomers were
reduced with 10 mM DTT for 1 h at 37 °C,
precipitated with 75% ammonium sulfate and redissolved in 200 mM Tris-HCl (pH 8.0), 200 mM NaCl, and 1 mM EDTA. For reoxidation of cysteines, oxidized and reduced glutathione were added to final concentrations of 9 and 0.9 mM, respectively (27). After 3 days, the peptides were
dialyzed against 5 mM sodium phosphate buffer (pH 7.4)
containing 150 mM NaCl.
For the analysis of hetero-oligomers by electrospray mass spectrometry,
all possible chain combinations involving two different proteins were
mixed at molar ratios of 1:1, 2:1, and 1:2 in the presence of 10 mM DTT and 5 M GuHCl, heated to 90 °C for 2 min, incubated for a further 1 h at 37 °C, and dialyzed against
5 mM sodium phosphate buffer (pH 7.4) containing 150 mM NaCl.
For isolation of specific hetero-oligomers, one His-tagged matrilin
chain was mixed with an excess of another non-His-tagged matrilin (two
in case of the heterotrimer comprising three different chains), heated
to 90 °C for 2 min, and incubated at 37 °C for 1 h. After
purification on Ni2+-Sepharose and removal of the His tag,
heteromers were dialyzed against 5 mM sodium phosphate
buffer (pH 7.4) containing 150 mM NaCl.
Gel Electrophoresis--
Nondenaturing PAGE and Tricine/SDS-PAGE
(28) were performed on 12 × 13-cm slab gels. Proteins were
visualized by staining with Coomassie Brilliant Blue R-250. Apparent
molecular masses were obtained by comparison with low molecular mass
markers (Amersham Biosciences and Sigma).
Mass Spectral Analyses--
For mass spectral analysis, the
peptides were chromatographed on a 100-µm inner diameter column
packed with Vydac C18 reverse-phase material (5-µm particle size).
The proteins were eluted with a linear 20-min gradient from 0.1%
trifluoroacetic acid to 80% acetonitrile plus 0.1% trifluoroacetic
acid at a flow rate of 1 µl/min. The outlet of the column was
directed to a microspray needle, which was pulled from 100-µm inner
diameter 280-µm outer diameter fused silica capillaries (LC Packings)
on a model P-2000 quartz micropipette puller (Sutter Instrument Co.).
The needle was placed into an XYZ micropositioner, and the voltage was
applied directly to the sample stream through the capillary union (29).
Spray voltages were usually between 1100 and 1400 V. Mass
determinations were carried out on a TSQ7000 triple quadrupole mass
spectrometer (Finnigan).
CD Spectroscopy--
The CD spectra were acquired on a Cary 61 spectropolarimeter (Varian). The far-ultraviolet spectra (200-250 nm)
were measured in a 1-mm path length quartz cell. The spectra were
normalized for concentration and path length to obtain the mean molar
residue ellipticity after subtraction of the buffer contribution.
Thermal transition profiles were recorded with a thermostatted 1-mm
path length quartz cell. Thermal stability was determined by monitoring the change in the mean molar residue ellipticity at a fixed wavelength of 221 nm, [
]221, as a function of temperature. A
heating rate of 1 °C/min was used. The GuHCl concentrations were
determined from the refractive index according to Pace (30). Data
analysis was performed with the Sigma Plot (Jandel Scientific) software package.
Analytical Ultracentrifugation--
Sedimentation equilibrium
and sedimentation velocity experiments were performed on a Beckman
Optima XL-A analytical ultracentrifuge (Beckman Instruments) equipped
with 12-mm Epon double-sector cells in an An-60 Ti rotor. The
recombinant proteins were analyzed in 5 mM sodium phosphate
buffer (pH 7.4) containing 150 mM NaCl. Protein
concentrations were adjusted to 0.2-1.2 mg/ml. Sedimentation velocity
runs were performed at a rotor speed of 54,000 rpm, and sedimenting
material was assayed by the absorbance at 234 nm. Sedimentation
coefficients were corrected to standard conditions (water, 20 °C;
Ref. 31). Sedimentation equilibrium measurements were carried out at
20 °C at rotor speeds from 22,000 to 28,000 rpm. Molecular masses
were evaluated in sedimentation equilibrium experiments from ln
A versus r2 plots, where
A represents the absorbance and r is the distance from the rotor center (31). A partial specific volume of 0.73 ml/g was
used for all calculations.
 |
RESULTS |
Design of the Matrilin Coiled-coil Proteins--
The amino acid
sequences of the four proteins termed ccMat1, ccMat2, ccMat3, and
ccMat4 are displayed in Fig.
1B. They were designed as
follows. 1) To obtain specific disulfide-linked oligomers, which can be
characterized by nonreducing SDS-PAGE and mass spectroscopy, the
conserved cysteine residues flanking the N terminus of the matrilin
coiled-coil domains were included in the proteins. For chicken
matrilin-1, it has been shown by NMR that these cysteines form a ring
of interchain disulfide bridges that stabilizes the coiled-coil
structure (32). Together with analytical ultracentrifugation measurements, the cysteines can also be useful to probe the relative helix orientation of the coiled-coils. 2) To be able to distinguish them by nondenaturing PAGE, all proteins were negatively charged but
differed in their net charge. For that purpose, two additional aspartate residues were introduced at the N terminus of ccMat2. Net
charges of the monomers are
1 for ccMat1,
3 for ccMat2,
2 for
ccMat3, and
4 for ccMat4. 3) To be able to quantitate the proteins by
tyrosine or/and tryptophan absorption, an artificial tryptophan residue
was included at the N terminus of ccMat1 and ccMat4.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
Design of the matrilin coiled-coil
domains. A, schematic color
representation of the domain organization of the four human
matrilins. Matrilin-4 occurs in alternatively spliced forms,
which differ in the number of their EGF-like repeats (for a review, see
Ref. 59). B, alignment of the coiled-coil domains from the
four human matrilin family members with numbers referring to
amino acid positions within the native proteins. Heptad repeats are
shown as blocks of seven residues, and heptad positions are indicated
by lowercase letters. Heptad positions a and d
are highlighted in blue, and cysteines are shown in
red. Residues added for protein quantitation or net charge
variation and amino acids originating from the expression plasmid are
shown in lowercase letters.
|
|
The Matrilin Coiled-coil Domains Form Specific Homo-oligomers of
High Thermal Stability--
The four recombinant proteins were
produced by expression in E. coli and purified as described
under "Experimental Procedures." The homogeneity of the recombinant
proteins was assessed by Tricine/SDS-PAGE under reducing conditions and
revealed single bands of the expected monomer molecular masses (Fig.
2A, lanes
1-4). After redox shuffling of the proteins,
Tricine/SDS-PAGE under nonreducing conditions revealed the specific
formation of covalently linked homotrimers for ccMat1, ccMat2, and
ccMat4 and a covalently linked homotetramer for ccMat3 (Fig.
2A, lanes 5-8). Consistent results
were obtained by electrospray mass spectrometry (Table
I). Moreover, analytical ultracentifugation sedimentation equilibrium studies confirmed the
oligomerization states of the peptides and indicated that the
peptides did not further assemble to higher aggregates (Table I).

View larger version (64K):
[in this window]
[in a new window]
|
Fig. 2.
The matrilin coiled-coil domains fold into
specific disulfide-linked homo-oligomers. A,
Tricine/SDS-PAGE analysis of the recombinant proteins under reducing
(lanes 1-4) and nonreducing conditions
(lanes 5-8). B, 12% nondenaturing
PAGE of the proteins in the presence (lanes 1-4)
and absence (lanes 5-8) of DTT. Lanes
1 and 5, ccMat1; lanes 2 and 6, ccMat2; lanes 3 and
7, ccMat3; lanes 4 and 8,
ccMat4.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Sedimentation coefficients (s20,w), molecular masses determined
by analytical ultracentrifugation and electrospray mass spectroscopy,
and Tm values determined by CD spectroscopy of the homotypic
matrilin coiled-coil domains
|
|
This finding was also supported by nondenaturing PAGE analysis of the
proteins (Fig. 2B). Nondenaturing gels separate on the basis
of a combination of molecular mass, shape, and net charge of proteins.
The relative migration of ccMat1, ccMat2, and ccMat4 homotrimers with
net charges of
3,
9, and
12, respectively, can be expected as a
result of their similar molecular masses and probably also similar
shapes (Fig. 2B, lanes 5,
6, and 8). The faster electrophoretic mobility of
the ccMat3 homotetramer with a net charge of
8 relative to that of
ccMat2 homotrimer may be explained by the formation of a more compact
structure, which is less resistant to migration in the electric field
(lane 7). Notably, a very similar pattern was
obtained in the presence of the reducing agent DTT (lanes
1-4), indicating that homo-oligomer formation of matrilins
is not dependent on disulfide bridge formation.
CD spectroscopy was used to test for the secondary structures of the
proteins. The far-ultraviolet CD spectra with minima near 208 and 222 nm (Fig. 3A) recorded from the
four matrilin coiled-coil domains at 5 °C and total chain
concentrations of 130 µM were characteristic for
-helical structures. Based on [
]221 values of about
33,000 degrees cm2 dmol
1 for 100%
-helix (33), helical contents of >80% were calculated. The thermal
stabilities of the four recombinant matrilin polypeptide chains were
assessed by temperature-induced unfolding profiles recorded by CD at
221 nm (Fig. 3B; Table I). Due to their high thermal
stabilities, GuHCl combined with increasing temperature was used to
completely unfold the proteins. The profiles exhibited the sigmoidal
shapes typical for coiled-coil structures. The Tm values obtained for the proteins are summarized in Table I. Only ccMat1
showed a biphasic transition, indicating cold denaturing. A similar
thermal unfolding profile was observed for the chicken matrilin-1
coiled-coil domain2 and the
pentameric coiled-coil domain of cartilage oligomeric matrix protein
(ccCOMP) in the presence of high GuHCl concentrations (34). All thermal
transitions were concentration-independent and reversible, with >90%
of the starting signal regained on cooling (data not shown).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 3.
The four recombinant matrilin proteins fold
into stable homotypic coiled-coil structures. A,
far-ultraviolet CD spectra recorded from the proteins in 5 mM sodium phosphate buffer (pH 7.4) containing 150 mM NaCl at 5 °C and total chain concentrations of 130 µM. Temperature-induced unfolding profiles of the
proteins monitored by CD following the change of the mean molar residue
ellipticity at 221 nm, [ ]221, under nonreducing
(B) and reducing (10 mM DTT) (C)
conditions are shown. The coiled-coil domains were analyzed under the
same buffer and concentration conditions as in A except that
the addition of GuHCl was necessary to completely unfold the proteins
under nonreducing conditions.
|
|
To test for the influence of disulfide bonds to their thermal
stability, the four proteins were unfolded in the presence of the
reducing agent DTT. Although all proteins still showed high thermal
stabilities, significantly lower Tm values and less
sharp transition profiles were obtained under reducing conditions without GuHCl (Fig. 3C). While ccMat1 only partially melted,
complete unfolding profiles were obtained for ccMat2, ccMat3, and
ccMat4. The Tm values of the reduced homo-oligomers
are summarized in Table I.
Taken together, all four matrilin proteins folded into disulfide-linked
coiled-coil structures of high thermal stabilities. Analytical
ultracentrifugation together with SDS-PAGE under nonreducing conditions
demonstrated that the helices of the four matrilin coiled-coils are
arranged in a parallel manner. Formation of these specific homotypic
structures was not dependent on disulfide bridge formation. The fact
that consistent oligomerization states were reported for the
full-length proteins demonstrates the validity of our approach.
The Matrilin Coiled-coil Domains Form Nine Distinct
Hetero-oligomers--
To investigate the properties of the four
matrilin coiled-coil domains for heterotypic assembly, all possible
chain combinations involving two different proteins were mixed at molar
ratios of 1:1, 2:1, and 1:2. Furthermore, all possible combinations
involving three different chains were mixed in equimolar amounts as
described under "Experimental Procedures."
To assess heteromer formation of the matrilin proteins and to determine
their chain stoichiometries, electrospray mass spectrometry was used
(Table II). With the exception of ccMat3,
which interacted only with ccMat1, heteromer formation was observed for
all other chain combinations. For all of these complexes,
disulfide-linked heterotrimeric structures were found, except for
ccMat1 and ccMat3, which folded into disulfide-linked tetramers. The
concentration of the individual peptides statistically determined the
stoichiometry of the heteromers. As a result, both possible
stoichiometries were obtained for the heterotrimers containing two
different chains, (ccMatX)1(ccMatY)2 and
(ccMatX)2(ccMatY)1 (where X represents 1, 2, or
4, and Y is 1, 2, or 4). Two different stoichiometries were also seen
for the heterotetramers, cc(Mat1)1(ccMat3)3,
and cc(Mat1)2(ccMat3)2. In contrast, a
heterotetramer containing one chain of ccMat3 and three chains of
ccMat1 was never observed. Interestingly, mass spectrometry revealed a
heterotrimer, consisting of three different chains of ccMat1, ccMat2,
and ccMat4.
View this table:
[in this window]
[in a new window]
|
Table II
Molecular masses determined by electrospray mass spectroscopy and
Tm values of the purified disulfide-linked matrilin
hetero-oligomers
|
|
The specificity of matrilin heteromer formation was demonstrated when
selected hetero-oligomers from each chain combination (Fig.
4, lanes 5-11)
were compared with the homo-oligomeric species (Fig. 4,
lanes 1-4) on nondenaturing gels. All
hetero-oligomers migrated at positions intermediate to their component
chains, indicating that the complexes adopt a compact structure with an intermediate net charge. Furthermore, a very similar pattern was obtained in the presence of DTT (Fig. 4, lanes
12-18), indicating that heterotypic interactions are
mediated by noncovalent interactions and are not dependent on disulfide
bridge formation. Fig. 4 shows no evidence for association of the
hetero-oligomers to higher aggregates, a result that is supported by
analytical ultracentrifugation of the purified
(ccMat1)1(ccMat2)1(ccMat4)1
complex. A molecular mass of 19.6 kDa and no higher aggregates were
observed, which is consistent with formation of a trimeric
structure.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 4.
The four matrilin coiled-coil domains form
distinct disulfide-linked isoforms. Heterotypic complex formation
of selected chain combinations under nonreducing (lanes
5-11) and reducing conditions (lanes
12-18) is shown in comparison with the homotypic matrilin
coiled-coils (lanes 1-4) on a 12% nondenaturing
gel at 4 °C. The chain composition of the heterotypic complexes is
indicated at the top.
|
|
The purified matrilin heteromers were further characterized by CD
spectroscopy. As expected, the far-ultraviolet CD spectra recorded from
the heterotypic coiled-coil domains were characteristic for
-helical
structures (data not shown). As judged from the CD signal at 221 nm,
all hetero-oligomers were >80% helical (data not shown).
Like those of the homo-oligomers, the thermal stabilities of the
heterotypic matrilin complexes required the addition of GuHCl for the
recording of temperature-induced unfolding profiles. The profiles were
recorded at total chain concentrations ranging from 20 to 100 µM. They were >90% reversible (data not shown) and, as
expected for covalently linked oligomers, concentration-independent (Fig. 5; Table II).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 5.
Matrilin isoforms form coiled-coil structures
of high thermal stabilities. The temperature-induced CD unfolding
profiles of selected hetero-oligomers in 5 mM sodium
phosphate buffer (pH 7.4) containing 150 mM NaCl and
appropriate concentrations of GuHCl are shown. The total chain
concentrations varied from 20 to 100 µM.
|
|
The thermal stability of heterotetramer
cc(Mat1)2(ccMat3)2 could be directly compared
with those of the component homo-oligomers, because all three species
were measured in the same GuHCl concentration of 5.8 M. The
value obtained for the heterotetramer is about 15 °C higher than the
average Tm value calculated from the homo-oligomers.
For the other pairs, for which transitions of homo- and
heteromers were measured at different GuHCl concentrations, Tm values of the homo-oligomers were corrected to
the GuHCl concentration of the hetero-oligomer. This was done with a
linear gradient of
Tm/
CGuHCl = 32 °C/1
M.2 Linearity was also proven for many other
systems.3 The corrected
Tm values for ccMat1 and ccMat2 in 4 M GuHCl were 112.4 °C and
9 °C, respectively, resulting in an
average value of 72 °C for
(ccMat1)2(ccMat2)1. This value is about 8 °C lower than the measured Tm obtained for the
heterotrimer (Table II). For the other heterotrimers, the
same tendency was observed. For
(ccMat1)2(ccMat4)1,
(ccMat2)1(ccMat4)2, and
(ccMat1)1(ccMat2)1(ccMat4)1, corrected Tm values of 72, 55, and 48 °C,
respectively, were calculated, which are 6, 3, and 27 °C,
respectively, lower than the measured values. These findings indicate
that matrilin hetero-oligomers are thermodynamically favored over
homo-oligomers.
Taken together, our results demonstrate that the four matrilin
coiled-coil domains can fold into nine disulfide-linked parallel hetero-oligomers. Notably, the formation of these distinct isoforms is
not dependent on disulfide bonds. Two of these chain combinations have
recently been reported for the full-length matrilin-1 and matrilin-3
proteins (6, 22-24). Together with the fact that coiled-coil domains
usually display the same oligomerization properties as the full-length
proteins, our findings strongly suggest that the other seven matrilin
isoforms also exist in nature. Although our results shed light on the
structural organization of matrilins, the functional significance of
heteromer formation remains to be elucidated.
 |
DISCUSSION |
As a step toward our goal to understand matrilin structure and
function, we have characterized the four human matrilin coiled-coil domains and all possible chain combinations therefrom by biochemical and biophysical methods. Coiled-coil domains usually display the same
oligomerization state as the full-length proteins but offer the
advantage of avoiding difficulties associated with the full-length proteins, such as supramolecular assembly. We found that ccMat1, ccMat2, and ccMat4 all formed disulfide-linked, three-stranded, parallel homotrimers, whereas ccMat3 folded into a disulfide-linked, four-stranded, parallel coiled-coil structure (Fig.
6). Consistent oligomerization states
have previously been reported for the full-length proteins (5-7, 35),
synthetic peptides, and recombinant proteins comprising the coiled-coil
domains from matrilin-1 and matrilin-2 (32, 36-38). Based on the
coiled-coil structures, we were able to identify nine different
matrilin isoforms, seven of which have not been described previously.
The possible matrilin chain combinations are shown in Fig. 6. An
unexpected feature of the matrilin hetero-oligomers consisting of two
different polypeptide chains is that they can exist in different
stoichiometries. The most plausible explanation for this observation is
that the thermodynamic stabilities of the heterotypic coiled-coils with
the same chain composition are very similar. Our studies not only
confirmed two heterotetramers of different chain stoichiometries
reported for biochemically isolated matrilin-1 and matrilin-3 (6, 23)
but also demonstrated that these interactions occur via the proteins'
coiled-coil domain. These findings emphasize the validity of our
approach and demonstrate that the characterization of the coiled-coil
domains from a protein family can be used to predict their
oligomerization properties.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 6.
Possible matrilin homo- and
hetero-oligomers. 1, matrilin-1; 2,
matrilin-2; 3, matrilin-3; 4, matrilin-4. The
same color code as in Fig. 1A is
used.
|
|
The
-helical coiled coil is the most widespread subunit
oligomerization motif found in proteins (39-42). It is a type of
protein structure consisting of 2-5 amphipathic
-helices that
"coil" around each other in a slight supertwist (39-42). The
sequences of left-handed coiled coils are characterized by a heptad
repeat of seven residues denoted a-g with a
3,4-hydrophobic repeat of mostly apolar amino acids at positions
a and d (43, 44). Interactions between the core
residues a and d and the two flanking
positions e and g determine the number of
strands, the parallel or antiparallel orientation of
-helices, and
the homo- or heterotypic association of subunits into a coiled coil
(for a review, see Refs. 39 and 42).
Matrilin-3 differs from the other matrilins in terms of its tetrameric
oligomerization state. It is well known that the residues at the
a and d positions can exert a major influence on
oligomer selection. Crucial roles in oligomer specification are played by leucine and the
-branched residue isoleucine (45). Tetramers are
known to be favored by sequences enriched by leucine residues at the
a sites and isoleucine at the d sites, whereas
trimers display a more even distribution of hydrophobic residues at
these positions. The preferences for specific amino acids at the core positions of coiled-coils can be explained by differences in packing geometry in these structures. Since only matrilin-3 contains a single
isoleucine residue at a d position of the third heptad repeat, it is tempting to speculate that this residue specifies the
four-stranded oligomerization state of the protein. Considering the
importance of isoleucine for specifying the oligomerization state,
chicken matrilin-3 may possibly even form a trimer because this residue
is not conserved in the avian species. In addition, the d
position of the fourth heptad repeat of all known matrilin-3 species is
occupied by residues that are not frequently found at these positions
(46). It should be noted that residues at the b,
c, e, and g positions of the tetramer
also contribute to the hydrophobic core (45). Thus, the amino acid
sequence at these positions can also influence the oligomerization
state. Accordingly, Beck et al. (37) observed a switch in
the oligomerization state of the coiled-coil domain of matrilin-1 after
substitution of a single residue. After replacing arginine 487, which
forms a potential interchain ionic interaction with a glutamate 492, with glutamine, the peptide folded into a homotetramer at neutral pH.
Interestingly, the mutant peptide folded into a homotrimer at acidic
and basic pH. It should be noted, however, that the interchain salt
bridge is an unlikely determinant in specifying the four-stranded
oligomerization state, because the interaction is conserved among the
human and mouse matrilins.
Our findings raise the question about the molecular determinants that
specify that matrilin-3 interacts with matrilin-1 but not with
matrilin-2 and matrilin-4. In line with our results, it has been
established by phylogenetic analysis that the coiled-coil domain of
ccMat3 is most closely related to ccMat1 (1). Interestingly, all
coiled-coil structures containing matrilin-3 are four-stranded. It is
well established that hetero-oligomerization can occur as a
"relief" of repulsive electrostatic interactions between residues in the g position with residues in the e'
position of a neighboring chain in a homo-oligomer (for a review, see
Ref. 47). Electrostatic interactions between residue i of
chain 1 in g and residue i' + 5 in e
of chain 2 are prominent because of the proximity of these residues
(45). Repulsive interactions disrupt the complementary packing at the
interface of the coiled-coil, thus accounting for the instability of
the homodimers. However, interchain g and e' interactions do not explain hetero-oligomer formation of matrilins. There is only one potential attractive interaction between residues of
the last two heptads that is conserved in all four coiled-coils (Arg or
Lys in g to Glu in e'; see Fig. 1B).
Tetramers also exhibit two types of ion pairs that are rarely found in
trimers. These are g to b' and c to
e' salt bridges. Like the e and g
residues, however, these salt bridges are unlikely to account for the
hetero-oligomerization specificity of matrilins. Furthermore,
hetero-oligomer formation of matrilins is not the result of
homo-oligomer instability, because all four homotypic matrilin
coiled-coils fold into very stable structures. Because electrostatic
interactions do not provide an explanation, we therefore suggest that
the heterotypic preferences seen for the matrilin coiled-coil domains
are the result of the packing of the hydrophobic core. Our hypothesis
is consistent with a recent study of Keating et al. (48),
who addressed the role of hydrophobic residues at the a and
d positions in determining heterotypic interaction
specificity. These authors showed that computational modeling of
coiled-coil structures can be used to predict interaction energy
differences that agree quantitatively with experimental results
positions in determining interaction specificity. The calculations
could be used to predict coiled-coil partnering preferences that arise
from core packing. Accordingly, residues that are known to favor trimer
or tetramer formation over dimerization (such as Ile or Val at the
d position) were found to destabilize the heterodimers.
The principal function of coiled-coil domains is subunit
oligomerization of multisubunit proteins. Oligomerization generates multivalency, provides high local concentrations of functional sites,
and allows clustered domains to function in a concerted manner.
Heteromers could further increase the structural and functional diversity of matrilins. Candidates are the vWFA domains, which are
arranged in different ways in different isoforms (for a schematic view,
see Figs. 1A and 6). These domains are present in a large number of other extracellular proteins, including collagens, complement factors, integrins, and von Willebrand factor (49, 50) and mediate
self-interaction and ligand-binding activities (49). Thus, the
ligand-binding affinity of vWFA domains could be modulated by the
expression of matrilins as homo- and hetero-oligomers. Such a mechanism
has also been proposed for the heparin-binding properties of
thrombospondins (51), where thrombospondin-2 has a lower affinity than
thrombospondin-1. Thus, the ligand-binding affinity could be varied by
the formation of thrombospondin homo- and heterotrimers. Coiled-coil
domains also play an important role in the formation of laminins for
which isoform-specific functions are well established (52, 53).
Laminins comprise a family of at least 14 heterotrimers that are
assembled through a coiled-coil domain from at least 11 different
polypeptide chains. Laminins function as structural components and are
essential for morphogenesis but in addition interact with cell surface
receptors such as integrins and
-dystroglycan. The many interactions
of laminins are mediated by binding sites, often contributed by single
domains, which may differ between different forms of laminin. One
important function of many laminins is their ability to self-associate
into independent networks (54). Since self-assembly is mediated by the
N-terminal domains, these interactions differ among isoforms.
The vWFA domain is the most likely candidate for the self-interaction
seen for matrilins, leading to the formation of supramolecular structures, which may play a role in stabilizing the extracellular matrix structure. Also in this case, hetero-oligomerization could provide a means to increase the structural diversity of these complexes
and generate assemblies with particular properties. This hypothesis is
supported by a recent study on collagen V by Chanut-Delalande et
al. (55). These authors investigated the role of collagen V in
homotypic and heterotypic fibril formation. They found that both
collagen V heterotrimer and homotrimer formed thin fibrils. When mixed
with collagen I, however, heterotrimer and homotrimer exerted different
effects in heterotypic fibril formation. Unlike the heterotrimer, which
was buried in the fibril interior, the homotrimer was localized as thin
filamentous structures at the surface of wide collagen I fibrils and
did not regulate fibril assembly. Its localization at the fibril
surface suggests that the homotrimer can act as a molecular linker
between collagen fibrils and/or macromolecules in the extracellular
matrix. Interestingly, like our findings on matrilin heteromer
formation, the control of collagen V homo- and heterotrimers seems to
be determined by chain stoichiometry.
Furthermore, coiled-coil domains can also harbor binding sites for
globular proteins. For example, the N-terminal domain of agrin binds to
the coiled-coil domain of laminins (56). This interaction is important
for the localization of agrin to the synaptic basal lamina and other
basement membranes. In the hyperthermophilic archaebacterium
Staphylothermus marinus, a subtilisin-like protease interacts with the four-stranded right-handed coiled coil of the surface layer protein tetrabrachion (57, 58). Likewise, particular matrilin isoforms may contain binding sites for extracellular proteins
that are not present in the homo-oligomers. Thus, depending on their
respective distribution in tissues, the different matrilin isoforms
might fulfill specific biological functions. This conclusion is also
supported by a study of Chapman et al. (12), who
demonstrated that mutations in the vWFA domain in matrilin-3 are
associated with multiple epiphyseal dysplasia.
The tissue distribution of matrilins indicates that some of the chain
combinations identified in this study are more prominent than others.
Matrilin-2 (5, 13) and matrilin-4 (7, 14, 15) have a broad tissue
distribution, whereas the expression of matrilin-1 (also known as
cartilage matrix protein) (9, 16, 17) and matrilin-3 (6, 18-20) is
more restricted to skeletal tissues. Our results on the identification
of distinct matrilin chain combinations strongly suggest that these
isoforms also exist in nature. The recombinant proteins may be used to raise isoform-specific antibodies to identify and monitor particular chain combinations in tissue.
Due to its small size the heterotrimeric coiled coil consisting of
matrilin-1, matrilin-2, and matrilin-4 should also be of interest as a
hetero-oligomerization tool. Homotypic and heterodimeric coiled coils
are frequently used to artificially cluster domains and peptides of
interest. Due to the high local concentrations, in many cases
clustering results in a significantly increased activity of the domains
and peptides.
 |
FOOTNOTES |
*
This work was supported by Swiss National Science Foundation
Grant 31-49281.96 (to J. E.) and Wellcome Trust Grant GBRK16 (to
R. A. K.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Biophysical Chemistry, Biozentrum, University of Basel,
Klingelbergstrasse 70, CH-4056 Basel, Switzerland. Tel.:
41-61-267-2250; Fax: 41-61-267-2189; E-mail:
juergen.engel@unibas.ch.
**
A Wellcome Trust Career Development Fellow.
Published, JBC Papers in Press, March 14, 2002, DOI 10.1074/jbc.M202146200
2
Y. Guo, R. A. Kammerer, and J. Engel,
unpublished data.
3
T. Kiefhaber, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
vWFA, von Willebrand
factor A domain;
EGF, epidermal growth factor;
DTT, dithiothreitol;
GuHCl, guanidine hydrochloride;
[
]221, mean molar residue ellipticity at 221 nm, Tm,
midpoint of thermal denaturation;
Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)-ethyl]glycine;
ccCOMP, coiled-coil domain of cartilage oligomeric matrix protein.
 |
REFERENCES |
| 1.
|
Deak, F.,
Wagener, R.,
Kiss, I.,
and Paulsson, M.
(1999)
Matrix Biol.
18,
55-64[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Winterbottom, N.,
Tondravi, M. M.,
Harrington, T. L.,
Klier, F. G.,
Vertel, B. M.,
and Goetinck, P. F.
(1992)
Dev. Dyn.
193,
266-276[Medline]
[Order article via Infotrieve]
|
| 3.
|
Chen, Q.,
Johnson, D. M.,
Haudenschild, D. R.,
Tondravi, M. M.,
and Goetinck, P. F.
(1995)
Mol. Biol. Cell
6,
1743-1753[Abstract]
|
| 4.
|
Chen, Q.,
Zhang, Y.,
Johnson, D. M.,
and Goetinck, P. F.
(1999)
Mol. Biol. Cell
10,
2149-2162[Abstract/Free Full Text]
|
| 5.
|
Piecha, D.,
Muratoglu, S.,
Morgelin, M.,
Hauser, N.,
Studer, D.,
Kiss, I.,
Paulsson, M.,
and Deak, F.
(1999)
J. Biol. Chem.
274,
13353-13361[Abstract/Free Full Text]
|
| 6.
|
Klatt, A. R.,
Nitsche, D. P.,
Kobbe, B.,
Morgelin, M.,
Paulsson, M.,
and Wagener, R.
(2000)
J. Biol. Chem.
275,
3999-4006[Abstract/Free Full Text]
|
| 7.
|
Klatt, A. R.,
Nitsche, D. P.,
Kobbe, B.,
Macht, M.,
Paulsson, M.,
and Wagener, R.
(2001)
J. Biol. Chem.
276,
17267-17275[Abstract/Free Full Text]
|
| 8.
|
Huang, X.,
Birk, D. E.,
and Goetinck, P. F.
(1999)
Dev. Dyn.
216,
434-441[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Paulsson, M.,
and Heinegard, D.
(1979)
Biochem. J.
183,
539-545[Medline]
[Order article via Infotrieve]
|
| 10.
|
Hauser, N.,
Paulsson, M.,
Heinegard, D.,
and Morgelin, M.
(1996)
J. Biol. Chem.
271,
32247-32252[Abstract/Free Full Text]
|
| 11.
|
Makihira, S.,
Yan, W.,
Ohno, S.,
Kawamoto, T.,
Fujimoto, K.,
Okimura, A.,
Yoshida, E.,
Noshiro, M.,
Hamada, T.,
and Kato, Y.
(1999)
J. Biol. Chem.
274,
11417-11423[Abstract/Free Full Text]
|
| 12.
|
Chapman, K. L.,
Mortier, G. R.,
Chapman, K.,
Loughlin, J.,
Grant, M. E.,
and Briggs, M. D.
(2001)
Nat. Genet.
28,
393-396[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Deak, F.,
Piecha, D.,
Bachrati, C.,
Paulsson, M.,
and Kiss, I.
(1997)
J. Biol. Chem.
272,
9268-9274[Abstract/Free Full Text]
|
| 14.
|
Wagener, R.,
Kobbe, B.,
and Paulsson, M.
(1998)
FEBS Lett.
436,
123-127[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Wagener, R.,
Kobbe, B.,
and Paulsson, M.
(1998)
FEBS Lett.
438,
165-170[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Paulsson, M.,
and Heinegard, D.
(1982)
Biochem. J.
207,
207-213[Medline]
[Order article via Infotrieve]
|
| 17.
|
Aszodi, A.,
Hauser, N.,
Studer, D.,
Paulsson, M.,
Hiripi, L.,
and Bosze, Z.
(1996)
Eur. J. Biochem.
236,
970-977[Medline]
[Order article via Infotrieve]
|
| 18.
|
Wagener, R.,
Kobbe, B.,
and Paulsson, M.
(1997)
FEBS Lett.
413,
129-134[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Belluoccio, D.,
and Trueb, B.
(1997)
FEBS Lett.
415,
212-216[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Belluoccio, D.,
Schenker, T.,
Baici, A.,
and Trueb, B.
(1998)
Genomics
53,
391-394[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Segat, D.,
Frie, C.,
Nitsche, P. D.,
Klatt, A. R.,
Piecha, D.,
Korpos, E.,
Deak, F.,
Wagener, R.,
Paulsson, M.,
and Smyth, N.
(2000)
Matrix Biol.
19,
649-655[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Wu, J. J.,
and Eyre, D. R.
(1998)
J. Biol. Chem.
273,
17433-17438[Abstract/Free Full Text]
|
| 23.
|
Kleemann-Fischer, D.,
Kleemann, G. R.,
Engel, D.,
Yates, J. R., III,
Wu, J. J.,
and Eyre, D. R.
(2001)
Arch. Biochem. Biophys.
387,
209-215[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Zhang, Y.,
and Chen, Q.
(2000)
J. Biol. Chem.
275,
32628-32634[Abstract/Free Full Text]
|
| 25.
|
Dong, H.,
Nilsson, L.,
and Kurland, C. G.
(1996)
J. Mol. Biol.
260,
649-663[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Edelhoch, H.
(1967)
Biochemistry
6,
1948-1954[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Efimov, V. P.,
Engel, J.,
and Malashkevich, V. N.
(1996)
Proteins
24,
259-262[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Schagger, H.,
and von Jagow, G.
(1987)
Anal. Biochem.
166,
368-379[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Davis, M. T.,
Stahl, D. C.,
Hefta, S. A.,
and Lee, T. D.
(1995)
Anal. Chem.
67,
4549-4556[Medline]
[Order article via Infotrieve]
|
| 30.
|
Pace, N. C.
(1986)
Methods Enzymol.
131,
266-280[Medline]
[Order article via Infotrieve]
|
| 31.
|
van Holde, K. E.
(1985)
Physical Biochemistry
, 2nd Ed.
, pp. 93-136, Prentice Hall, Englewood Cliffs, NJ
|
| 32.
|
Dames, S. A.,
Kammerer, R. A.,
Wiltscheck, R.,
Engel, J.,
and Alexandrescu, A. T.
(1998)
Nat. Struct. Biol.
5,
687-691[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Chen, Y.-H.,
Yang, J. T.,
and Chau, K. H.
(1974)
Biochemistry
13,
3350-3359[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Guo, Y.,
Kammerer, R. A.,
and Engel, J.
(2000)
Biophys. Chem.
85,
179-186[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Hauser, N.,
and Paulsson, M.
(1994)
J. Biol. Chem.
269,
25747-25753[Abstract/Free Full Text]
|
| 36.
|
Beck, K.,
Gambee, J. E.,
Bohan, C. A.,
and Bachinger, H. P.
(1996)
J. Mol. Biol.
256,
909-923[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Beck, K.,
Gambee, J. E.,
Kamawal, A.,
and Bachinger, H. P.
(1997)
EMBO J.
16,
3767-3777[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Pan, O. H.,
and Beck, K.
(1998)
J. Biol. Chem.
273,
14205-14209[Abstract/Free Full Text]
|
| 39.
|
Cohen, C.,
and Parry, D. A.
(1990)
Proteins
7,
1-15[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Kammerer, R. A.
(1997)
Matrix Biol.
15,
555-568[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Kohn, W. D.,
Mant, C. T.,
and Hodges, R. S.
(1997)
J. Biol. Chem.
272,
2583-2586[Free Full Text]
|
| 42.
|
Lupas, A.
(1996)
Trends Biochem. Sci.
21,
375-382[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
McLachlan, A. D.,
and Stewart, M.
(1975)
J. Mol. Biol.
98,
293-304[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Sodek, J.,
Hodges, R. S.,
Smillie, L. B.,
and Jurasek, L.
(1972)
Proc. Natl. Acad. Sci. U. S. A.
69,
3800-3804[Abstract/Free Full Text]
|
| 45.
|
Harbury, P. B.,
Zhang, T.,
Kim, P. S,
and Alber, T.
(1993)
Science
262,
1401-1407[Abstract/Free Full Text]
|
| 46.
|
Woolfson, D. N.,
and Alber, T.
(1995)
Protein Sci.
4,
1596-1607[Abstract]
|
| 47.
|
Hodges, R. S.
(1996)
Biochem. Cell Biol.
74,
133-154[Medline]
[Order article via Infotrieve]
|
| 48.
|
Keating, A. E.,
Malashkevich, V. N.,
Tidor, B.,
and Kim, P. S.
(2001)
Proc. Natl. Acad. Sci.
98,
14825-14830[Abstract/Free Full Text]
|
| 49.
|
Colombatti, A.,
and Bonaldo, P.
(1991)
Blood
77,
2305-2315[Free Full Text]
|
| 50.
|
Lee, J. O.,
Rieu, P.,
Arnaout, M. A.,
and Liddington, R.
(1995)
Cell
80,
631-638[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
O'Rourke, K. M.,
Laherty, C. D.,
and Dixit, V. M.
(1992)
J. Biol. Chem.
267,
24921-24924[Abstract/Free Full Text]
|
| 52.
|
Timpl, R.,
and Brown, J. C.
(1994)
Matrix Biol.
14,
275-281[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Colognato, H.,
and Yurchenco, P. D.
(2000)
Dev. Dyn.
218,
213-234[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Cheng, Y. S.,
Champliaud, M. F.,
Burgeson, R. E.,
Marinkovich, M. P.,
and Yurchenco, P. D.
(1997)
J. Biol. Chem.
272,
31525-31532[Abstract/Free Full Text]
|
| 55.
|
Chanut-Delalande, H.,
Fichard, A.,
Bernocco, S.,
Garrone, R.,
Hulmes, D. J.,
and Ruggiero, F.
(2001)
J. Biol. Chem.
276,
24352-24359[Abstract/Free Full Text]
|
| 56.
|
Kammerer, R. A.,
Schulthess, T.,
Landwehr, R.,
Schumacher, B.,
Lustig, A.,
Yurchenco, P. D.,
Ruegg, M. A.,
Engel, J.,
and Denzer, A. J.
(1999)
EMBO J.
18,
6762-6770[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Peters, J.,
Nitsch, M.,
Kuhlmorgen, B.,
Golbik, R.,
Lupas, A.,
Kellermann, J.,
Engelhardt, H.,
Pfander, J. P.,
Muller, S.,
Goldie, K.,
Engel, A.,
Stetter, K.-O.,
and Baumeister, W.
(1995)
J. Mol. Biol.
245,
385-401[CrossRef][Medline]
[Order article via Infotrieve]
|
| 58.
|
Peters, J.,
Baumeister, W.,
and Lupas, A.
(1996)
J. Mol. Biol.
257,
1031-1041[CrossRef][Medline]
[Order article via Infotrieve]
|
| 59.
|
Paulsson, M.,
Piecha, D.,
Segat, D.,
Smyth, N.,
and Wagener, R.
(1999)
Biochem. Soc. Trans.
27,
824-826[Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Nicolae, Y.-P. Ko, N. Miosge, A. Niehoff, D. Studer, L. Enggist, E. B. Hunziker, M. Paulsson, R. Wagener, and A. Aszodi
Abnormal Collagen Fibrils in Cartilage of Matrilin-1/Matrilin-3-deficient Mice
J. Biol. Chem.,
July 27, 2007;
282(30):
22163 - 22175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Snellman, A. Tuomisto, A. Koski, A. Latvanlehto, and T. Pihlajaniemi
The Role of Disulfide Bonds and {alpha}-Helical Coiled-coils in the Biosynthesis of Type XIII Collagen and Other Collagenous Transmembrane Proteins
J. Biol. Chem.,
May 18, 2007;
282(20):
14898 - 14905.
[Abstract]
[Full Text]
[PDF]
|
 |
|